- Anna's DayBreak News
- Posts
- Terror Attacks in US Soil, Minimum Wage Proposals and Reverse Osteoporosis
Terror Attacks in US Soil, Minimum Wage Proposals and Reverse Osteoporosis
Anna's Daybreak News
Just facts, you think for yourself
Friday, 5:11 AM
March 13, 2026
Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟
Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.
Terror Attacks in US Soil
Mohamed Bailor Jalloh, recently released early from an 11-year terrorism sentence, killed one and wounded two Army personnel at Old Dominion University before being killed by ROTC students.
He shouted "Allahu Akbar" and targeted an ROTC class. In Michigan, Ayman Ghazali, a 41-year-old naturalized citizen from Lebanon, rammed a truck into Temple Israel synagogue and opened fire, injuring one security guard.
Ghazali lost multiple relatives in recent Israeli strikes on Lebanon. Both attacks are under federal investigation as terrorism.
U.S. authorities increased security at schools and places of worship nationwide following the twin incidents.
Sources: AP News, AP News, Bloomberg, Detroitnews, BBC
Should “credible indicators” of radicalization trigger mandatory check-ins (e.g., probation-style supervision), even without a new crime?Click to see live results and comment! |
Look, when one executive sells stock, it’s "liquidity." When three different C-suite heavyweights at a Top 3 US Bank dump nearly $10 million in the same 7-day window—and it’s not a pre-planned schedule—it’s a signal.
While the retail crowd is buying the "soft landing" narrative, the people running the vaults are hitting the 'Exit' button. This isn't a coincidence; it’s a coordinated de-risking move that usually precedes a major pullback. But that's only the first layer.
This week, we also uncovered:
The $200M Ghost: A massive mystery spender just landed in DC to lobby "Securities and Markets." They went from $0 to the GDP of a small country in spending overnight. If you don't know who this is, you're the patsy.
The CFO's Quiet Exit: A CFO at a high-flying, volatile tech giant just slashed their ownership by double digits. They see something the "diamond hands" crowd is missing.
The "Conviction Buy": Amidst the selling, one lone insider at a regional bank just went "all in" after being totally cashed out.
Don't be the last one holding the bag while the insiders move to cash. Get the full "Exit" list and our Action Plan below.
Straits, Sanctions, and Supply
The US Treasury expanded permissions for buyers to purchase Russian oil loaded before March 12, easing supply amid Middle East tensions.
About 124 million barrels of Russian oil are at sea, equal to five or six days’ flow through the Strait of Hormuz, where daily oil transit has dropped below one million barrels. Most shipments now use Chinese- and Russian-controlled tankers.
Brent crude trades near $101 per barrel. The US plans Navy escorts for commercial ships through the strait when conditions improve, but blockage risks remain.
US forces responded to a KC-135 crash in Iraq. Since February 28, about 6,000 strikes targeted Iranian forces.
Sources: Bloomberg, WallStreetJournal, WallStreetJournal
The US allowed purchase of Russian oil already at sea to ease price pressures. How do you feel about this move?Click to see live results and comment! |
New York City’s $30 Minimum Wage Proposal
New York City’s City Council proposed raising the minimum wage to $30 hourly, up from $17 now. Large firms (500+ employees) must reach $20 by 2027 and $30 by 2030; smaller businesses have until 2032.
The increase affects 1.68 million workers. The bill phases out the tip credit by 2032, requiring tipped workers to earn eventually full minimum wage. It mandates employer wage posting, recordkeeping, and prohibits retaliation.
Enforcement includes fines, back pay, and lawsuits. Supporters cite poverty relief; opponents warn of business costs, potential layoffs, price hikes, and note past job losses in Seattle post-wage hikes.
Legal challenges argue NYC may lack authority, possibly delaying implementation.
Sources: WallStreetJournal, Fisherphillips, Chosun
Do you think that a $30 minimum wage will lead to significant job losses or reduced hours for workers in NYC?Click to see live results and comment! |
Adobe’s CEO Steps Down
Adobe CEO Shantanu Narayen will step down after 18 years but remain chairman until a successor is found. Adobe posted Q1 revenue of $6.4 billion, up 12%, beating estimates, with adjusted EPS of $6.06 versus $5.88 expected.
Subscription revenue rose 13% to $4.39 billion from creative customers and $1.78 billion from business users. AI-focused annual recurring revenue tripled year-over-year, exceeding $250 million as of September 2025.
The company forecasts Q2 revenue between $6.43 billion and $6.48 billion, with EPS of $5.80 to $5.85.
Shares fell 7% after the CEO announcement, hitting a three-year low amid concerns about Adobe’s AI strategy and leadership transition.
Sources: Bloomberg, WallStreetJournal
Do you think most CEOs are ready to tackle the era of AI?Click to see live results and comment! |
Colon Cancer Clues
Colorectal cancer rates are rising in U.S. adults under 50, now the leading cause of cancer deaths in this group. A study analyzed colon tissue from 33 patients, revealing stiffer colon tissue in younger patients due to fibrotic tissue with excess collagen.
This stiffness was found in both cancerous and adjacent healthy tissue. Experiments showed that cancer cells grow faster in stiffer environments, regardless of patient age.
The findings suggest that increased tissue stiffness creates conditions that promote early tumor development.
This biomechanical insight could lead to new approaches in diagnosing, preventing, and treating early-onset colorectal cancer, which has been increasing for 30 years.
Sources: SciTechDaily
How confident are you that targeting physical tissue changes could transform early-onset colorectal cancer outcomes in the next decade?Click to see live results and comment! |
Reverse Osteoporosis
Researchers identified the receptor GPR133 as key to bone density; activating it with chemical AP503 increased bone strength in mice, especially with exercise.
A hormone called maternal brain hormone (MBH) also enhanced bone density and mineralization in male and female mice.
A new blood-based, synthetic peptide implant promotes bone repair by reinforcing blood clots, showing success in rats and potential for 3D printing and human use.
Current osteoporosis treatments mainly slow bone loss, but these findings focus on rebuilding weakened bones.
Although tested mostly in animals, these advances could lead to therapies improving bone strength and repair for aging populations and those with osteoporosis.
Sources: Sciencealert
Would you be willing to participate in a clinical trial testing hormone-based therapies for osteoporosis?Click to see live results and comment! |
“Genuine courtesy is just a man rolling up his sleeves and doing his duty. That other kind—the fancy, bowing-and-scraping, utterly useless kind—is just a lie wearing a Sunday suit. It ain't a sign of respect at all; it's a crowbar used to pry open a situation to their own advantage. When a fellow like that bends over backwards to flatter you, you can be certain he ain't bowing to your noble character; he's bowing to your bank account.”
Information is free. Intelligence is scarce.
You are one of 550,000 readers receiving this briefing. That is a crowd.
To join the 1,600 investors who receive our redacted contract briefings and wealth defense protocols, you need to step behind the velvet rope.
Join the Inner Circle.
Baked with love,
Anna Eisenberg ❤️
What did you think of today's edition?Click to see live results and comment! |
*Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product. Compounded medications are not reviewed by the FDA for safety, efficacy, or quality.
